Bipartisan push for permitting reform gains momentum as parties unite on energy infrastructure needs to power artificial intelligence revolution.
2026 is set to be a year of transition for the Danish drugmaker, as it faces headwinds including lower pricing on multiple fronts and patent expiries in Brazil, Canada, and China. It follows a ...
Hosted on MSN
Novo Nordisk enters 2026 on the defense as it faces a 'must-win' battle in the US market
2026 is set to be a year of transition for the Danish drugmaker, as it faces headwinds including lower pricing on multiple fronts and patent expiries in Brazil, Canada, and China. It follows a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results